Volume : 13, Issue : 09, September – 2026

Title:

FORMULATION AND EVALUATION OF FLUCYTOSINE LOADED INVASOMAL GEL

Authors :

Manu Kumar Singh*, Dr. Sandesh Asati, Dr. Brijesh Sirohi, Dr. Vishnu Raj

Abstract :

The present study aimed to develop and evaluate a flucytosine-loaded invasomal gel for improved topical antifungal drug delivery. Nine invasomal formulations (F1–F9) were prepared by varying terpene and phosphatidylcholine concentrations while maintaining flucytosine concentration at 1% w/v. The prepared invasomes were evaluated for entrapment efficiency and vesicle size. Among the formulati1ons, F9 exhibited the highest entrapment efficiency of 89.48% and the lowest vesicle size of 178.4 nm and was selected as the optimized invasome. The optimized invasomes were incorporated into Carbopol 934 gel at different polymer concentrations to prepare IG-1, IG-2 and IG-3. The formulations were evaluated for viscosity, pH, drug content, extrudability and spreadability. IG-2 demonstrated a suitable combination of physicochemical properties, with viscosity of 3924 ± 18 cps, pH 5.89 ± 0.02, drug content 99.46 ± 0.21%, extrudability 178 ± 2 g and spreadability 11.64 ± 0.27 g·cm/s, and was selected as the optimized invasomal gel. In-vitro drug-release studies showed sustained release from IG-2, with 89.46% cumulative drug release at 12 h compared with 88.65% release of pure flucytosine within 5 h. The release kinetics showed the highest correlation with the first-order and Higuchi models (R² = 0.9892), indicating an important contribution of diffusion to drug release. The optimized gel also exhibited enhanced antifungal activity against Candida albicans, producing zones of inhibition of 15.62 ± 0.24, 21.48 ± 0.29 and 27.36 ± 0.31 mm at 10, 20 and 30 µg/mL, respectively, compared with 12.36 ± 0.28, 16.74 ± 0.32 and 20.58 ± 0.35 mm for pure flucytosine. Stability studies further demonstrated satisfactory physical stability of IG-2 for six months at 4 ± 2°C and 25 ± 2°C. The findings indicate that the flucytosine-loaded invasomal gel may serve as a promising topical delivery system providing sustained drug release and enhanced antifungal activity.
Keywords: Flucytosine, Invasomes, Invasomal gel, Carbopol 934, Topical drug delivery, Sustained drug release, Candida albicans, Antifungal activity.

Cite This Article:

Please cite this article in press Manu Kumar Singh et al., Formulation And Evaluation Of Flucytosine Loaded Invasomal Gel. Indo Am. J. P. Sci, 2026; 13(09).

REFERENCES:

• Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections. Prim Care. 2015;42(4):501-516.
• Fang XF, Li D, Tangadanchu VK, Gopala L, Gao WW, Zhou CH. Novel potentially antifungal hybrids of 5-flucytosine and fluconazole: design, synthesis and bioactive evaluation. Bioorg Med Chem Lett. 2017;27(22):4964-4969.
• Akhtar N, Verma A, Pathak K. Topical delivery of drugs for the effective treatment of fungal infections of skin. Curr Pharm Des. 2015;21(20):2892-2913.
• Akombaetwa N, Ilangala AB, Thom L, Memvanga PB, Witika BA, Buya AB. Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications. Pharmaceutics. 2023;15(2):656.
• Kumar D, Sil D, Kurmi BD, Kumar M. Future prospects and regulatory pathways for invasome technologies in transdermal drug delivery. Assay Drug Dev Technol. 2025;23(3):115-135.
• Doroshenko KM, Shevchenko OI. From liposomes to virosomes: evolution of phospholipid nanocarriers in drug delivery. Biotechnol J. 2026;21(1):e70178.
• Kumar B, Pandey M, Aggarwal R, Sahoo PK. A comprehensive review on invasomal carriers incorporating natural terpenes for augmented transdermal delivery. Future J Pharm Sci. 2022;8(1):50.
• Dragicevic-Curic N, Gräfe S, Albrecht V, Fahr A. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study. J Photochem Photobiol B. 2008;91(1):41-50.
• Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm. 2005;290(1-2):155-159.
• El-Kattan AF, Asbill CS, Kim N, Michniak BB. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm. 2001;215:229-240.
• Amnuaikit T, Limsuwan T, Khongkow P, Boonme P. Vesicular carriers containing phenylethyl resorcinol for topical delivery system: liposomes, transfersomes and invasomes. Asian J Pharm Sci. 2018;13(5):472-484.
• Manchanda S, Sahoo PK. Fabrication and characterization of mucoadhesive topical nanoformulations of dorzolamide HCl for ocular hypertension. J Pharm Investig. 2018;48:323-332.
• Singh P, Jain G, Namdev P, Singhai A. Formulation and evaluation of luliconazole loaded invasomes. Asian J Pharm Educ Res. 2020;10(4):79-88.
• Kumar B, Sahoo P, Manchanda S. Development of eucalyptol enriched nano vesicles for better transdermal delivery of curcumin: preparation, characterisation and ex vivo skin analysis. Nanomed J. 2022;9(3):223-230.
• Chandra A, Aggarwal G, Manchanda S, Narula A. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharm Nanotechnol. 2019;7(5):362-374.
• Bachhav YG, Patravale VB. Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech. 2009;10(2):476-481.
• Sareen R, Kumar S, Gupta GD. Meloxicam carbopol-based gels: characterization and evaluation. Curr Drug Deliv. 2011;8(4):407-415.
• Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today. 2007;12(23-24):1061-1067.
• Nikhita K, Ruty Z. Formulation and evaluation of invasomal gel. Indo Am J Pharm Sci. 2024;11(12):437-448.